Didem Saygin to Prospective Studies
This is a "connection" page, showing publications Didem Saygin has written about Prospective Studies.
Connection Strength
0.609
-
Responsiveness and meaningful thresholds of PROMIS pain interference, fatigue, and physical function forms in adults with idiopathic inflammatory myopathies: Report from the OMERACT Myositis Working Group. Semin Arthritis Rheum. 2024 Feb; 64:152339.
Score: 0.162
-
Immune Checkpoint Inhibitor-Associated Myositis: A Distinct Form of Inflammatory Myopathy. J Clin Rheumatol. 2022 Oct 01; 28(7):367-373.
Score: 0.146
-
Hand-held dynamometry for assessment of muscle strength in patients with inflammatory myopathies. Rheumatology (Oxford). 2021 May 14; 60(5):2146-2156.
Score: 0.136
-
Follow-up results of myositis patients treated with H. P. Acthar gel. Rheumatology (Oxford). 2020 Oct 01; 59(10):2976-2981.
Score: 0.130
-
Reliability, validity and responsiveness of physical activity monitors in patients with inflammatory myopathy. Rheumatology (Oxford). 2021 Dec 01; 60(12):5713-5723.
Score: 0.035